SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-19-140458
Filing Date
2019-05-08
Accepted
2019-05-08 07:20:54
Documents
64
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d931681d10q.htm 10-Q 353044
2 EX-31.1 d931681dex311.htm EX-31.1 6420
3 EX-31.2 d931681dex312.htm EX-31.2 6407
4 EX-32.1 d931681dex321.htm EX-32.1 4014
5 EX-32.2 d931681dex322.htm EX-32.2 3929
  Complete submission text file 0001193125-19-140458.txt   2925509

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT srra-20190331.xml EX-101.INS 458920
7 XBRL TAXONOMY EXTENSION SCHEMA srra-20190331.xsd EX-101.SCH 41245
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE srra-20190331_cal.xml EX-101.CAL 55608
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE srra-20190331_def.xml EX-101.DEF 134695
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE srra-20190331_lab.xml EX-101.LAB 356421
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE srra-20190331_pre.xml EX-101.PRE 241553
Mailing Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8
Business Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8 604-558-6536
Sierra Oncology, Inc. (Filer) CIK: 0001290149 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37490 | Film No.: 19805158
SIC: 2834 Pharmaceutical Preparations